Albert Batushansky1, Satoshi Matsuzaki1, Maria F Newhardt1,2, Melinda S West1, Timothy M Griffin1,2,3, Kenneth M Humphries4,5. 1. Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, US. 2. Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, US. 3. Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, US. 4. Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, US. kenneth-humphries@omrf.org. 5. Department of Biochemistry and Molecular Biology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, 73104, US. kenneth-humphries@omrf.org.
Abstract
INTRODUCTION: As an insulin sensitive tissue, the heart decreases glucose usage during fasting. This response is mediated, in part, by decreasing phosphofructokinase-2 (PFK-2) activity and levels of its product fructose-2,6-bisphosphate. However, the importance of fructose-2,6-bisphosphate in the fasting response on other metabolic pathways has not been evaluated. OBJECTIVES: The goal of this study is to determine how sustaining cardiac fructose-2,6-bisphosphate levels during fasting affects the metabolomic profile. METHODS: Control and transgenic mice expressing a constitutively active form of PFK-2 (GlycoHi) were subjected to either 12-h fasting or regular feeding. Animals (n = 4 per group) were used for whole-heart extraction, followed by gas chromatography-mass spectrometry metabolic profiling and multivariate data analysis. RESULTS: Principal component analysis displayed differences between Control and GlycoHi groups under both fasting and fed conditions while a clear response to fasting was observed only for Control animals. However, pathway analysis revealed that these smaller changes in the GlycoHi group were significantly associated with branched-chain amino acid (BCAA) metabolism (~ 40% increase in all BCAAs). Correlation network analysis demonstrated clear differences in response to fasting between Control and GlycoHi groups amongst most parameters. Notably, fasting caused an increase in network density in the Control group from 0.12 to 0.14 while the GlycoHi group responded oppositely (0.17-0.15). CONCLUSIONS: Elevated cardiac PFK-2 activity during fasting selectively increases BCAAs levels and decreases global changes in metabolism.
INTRODUCTION: As an insulin sensitive tissue, the heart decreases glucose usage during fasting. This response is mediated, in part, by decreasing phosphofructokinase-2 (PFK-2) activity and levels of its product fructose-2,6-bisphosphate. However, the importance of fructose-2,6-bisphosphate in the fasting response on other metabolic pathways has not been evaluated. OBJECTIVES: The goal of this study is to determine how sustaining cardiac fructose-2,6-bisphosphate levels during fasting affects the metabolomic profile. METHODS: Control and transgenic mice expressing a constitutively active form of PFK-2 (GlycoHi) were subjected to either 12-h fasting or regular feeding. Animals (n = 4 per group) were used for whole-heart extraction, followed by gas chromatography-mass spectrometry metabolic profiling and multivariate data analysis. RESULTS: Principal component analysis displayed differences between Control and GlycoHi groups under both fasting and fed conditions while a clear response to fasting was observed only for Control animals. However, pathway analysis revealed that these smaller changes in the GlycoHi group were significantly associated with branched-chain amino acid (BCAA) metabolism (~ 40% increase in all BCAAs). Correlation network analysis demonstrated clear differences in response to fasting between Control and GlycoHi groups amongst most parameters. Notably, fasting caused an increase in network density in the Control group from 0.12 to 0.14 while the GlycoHi group responded oppositely (0.17-0.15). CONCLUSIONS: Elevated cardiac PFK-2 activity during fasting selectively increases BCAAs levels and decreases global changes in metabolism.
Authors: Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker Journal: Genome Res Date: 2003-11 Impact factor: 9.043
Authors: Tao Li; Zhen Zhang; Stephen C Kolwicz; Lauren Abell; Nathan D Roe; Maengjo Kim; Bo Zhou; Yang Cao; Julia Ritterhoff; Haiwei Gu; Daniel Raftery; Haipeng Sun; Rong Tian Journal: Cell Metab Date: 2017-02-07 Impact factor: 27.287
Authors: Dan Shao; Outi Villet; Zhen Zhang; Sung Won Choi; Jie Yan; Julia Ritterhoff; Haiwei Gu; Danijel Djukovic; Danos Christodoulou; Stephen C Kolwicz; Daniel Raftery; Rong Tian Journal: Nat Commun Date: 2018-07-26 Impact factor: 14.919
Authors: Maria F Newhardt; Albert Batushansky; Satoshi Matsuzaki; Zachary T Young; Melinda West; Ngun Cer Chin; Luke I Szweda; Michael Kinter; Kenneth M Humphries Journal: J Biol Chem Date: 2019-09-27 Impact factor: 5.157
Authors: Ammaji Rajala; Kenneth Teel; Mohd A Bhat; Albert Batushansky; Timothy M Griffin; Lindsey Purcell; Raju V S Rajala Journal: Cell Death Dis Date: 2022-07-15 Impact factor: 9.685
Authors: Craig A Eyster; Satoshi Matsuzaki; Maria F Newhardt; Jennifer R Giorgione; Kenneth M Humphries Journal: PLoS One Date: 2020-08-20 Impact factor: 3.240